Total sales of oral solid opioids in the U.S. 2010-2017
In 2017, total sales generated by prescribed oral solid opioids in the United States totaled 4.57 billion U.S. dollars, compared to nearly seven billion dollars in 2014. The compound annual growth rate (CAGR) for the period 2010-2017 was minus five percent.